Georgetown University Hospital - Dept of Neurology
Washington, District of Columbia, United States
Hospital in Washington, D.C.
3800 Reservoir Road Northwest Pasquerilla Healthcare Center 7th Floor, Washington, DC 20007
About Georgetown University Hospital - Dept of Neurology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Enterin Inc.
2
Alzheimer's Disease Cooperative Study (ADCS)
1
Eisai Inc.
1
National Institute on Aging (NIA)
1
Novartis
1
OPKO Health, Inc.
1
Pfizer
1
Theravance Biopharma
1
Clinical Trials at Georgetown University Hospital - Dept of Neurology
During the past decade, Georgetown University Hospital - Dept of Neurology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Nicotine Treatment of Mild Cognitive Impairment (MCI)
2003-09-01
2008-07-01
Unknown status
75
Rufinamide Given as Adjunctive Therapy in Participants With Refractory Partial Seizures
2006-02-13
2009-05-20
Completed
356
Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis
2006-06-01
2011-08-01
Completed
1,083
DHA (Docosahexaenoic Acid), an Omega 3 Fatty Acid, in Slowing the Progression of Alzheimer's Disease
2007-02-01
2009-05-01
Completed
402
ELND005 in Patients With Mild to Moderate Alzheimer's Disease
2007-12-01
2010-05-01
Completed
353
Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Early Alzheimer's Disease
2011-02-01
2014-02-01
Completed
63
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
2017-05-11
2018-06-14
Completed
50
Clinical Effect of Ampreloxetine (TD-9855) for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure
2019-01-24
2021-07-21
Completed
195
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Georgetown University Hospital - Dept of Neurology" #1 sponsor was "Enterin Inc." with 2 trials, followed by "Alzheimer's Disease Cooperative Study (ADCS)" with 1 trials
sponsored, "Eisai Inc." with 1 trials sponsored, "National Institute on Aging (NIA)" with 1 trials sponsored and "Novartis"
with 1 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Georgetown University Hospital - Dept of Neurology"
#1 collaborator was "DSM Nutritional Products, Inc." with 1 trials as a collaborator, "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 1 trials as a collaborator and "National Institute on Aging (NIA)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Georgetown University Hospital - Dept of Neurology
According to Clinical.Site data, the most researched conditions in "Georgetown University Hospital - Dept of Neurology" are
"Alzheimer's Disease" (2 trials), "Constipation" (2 trials), "Age-Related Memory Disorders" (1 trials), "Alzheimer Disease" (1 trials) and "Epilepsy" (1 trials). Many other conditions were trialed in "Georgetown University Hospital - Dept of Neurology" in a lesser frequency.
Clinical Trials Intervention Types at Georgetown University Hospital - Dept of Neurology
Most popular intervention types in "Georgetown University Hospital - Dept of Neurology" are "Drug" (8 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "ACC-001 10 μg/ QS-21 50 μg" (1 trials), "ACC-001 3 μg/ QS-21 50 μg" (1 trials), "Active Investigational Treatment ENT-01" (1 trials) and "DHA (Docosahexaenoic Acid)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Georgetown University Hospital - Dept of Neurology
The vast majority of trials in "Georgetown University Hospital - Dept of Neurology" are
9 trials for "All" genders.
Clinical Trials Status at Georgetown University Hospital - Dept of Neurology
Currently, there are NaN active trials in "Georgetown University Hospital - Dept of Neurology".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Georgetown University Hospital - Dept of Neurology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Georgetown University Hospital - Dept of Neurology, 2 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".